Use LEFT and RIGHT arrow keys to navigate between flashcards;
Use UP and DOWN arrow keys to flip the card;
H to show hint;
A reads text to speech;
19 Cards in this Set
- Front
- Back
why are there fewer antiviral drugs compared to antibacterial? (3)
|
1. selective toxicity is mandatory b/c viral infection involved host cells
2. infecton may be advanced before it is detected 3. rapid mutation of viruses |
|
what are targets of antiviral agents? (6)
|
block attachment/penetration;
block uncoating block NA syn block protein syn block assembly block release |
|
what block attachment, penetration?
|
fusion inhibitors;
receptor antagonists |
|
what blocks uncoating?
|
neutralizing agents;
crosslinking agents; |
|
what blocks NA syn?
|
base analogs
agents that inhibit nucleotide syn, DNA polym, reverse transcriptase |
|
what blocks protein syn?
|
interferons!
|
|
what blocks assembly?
|
protease inhibitors
|
|
what blocks release?
|
neuraminidase and hemagglutinin inhibitors
|
|
resistance to antiviral agents? (3)
|
mutated target
alter drug decr uptake (if required intracellularly) |
|
Fusion inhibitor (1)
|
Enfuviritide (Fuzeon)
-for HIV |
|
neutralizing agents (2)
|
Amantadine
Rimantadine |
|
base analog (mxn?)
|
AZT (nucleoside RT inhibitor)
|
|
inhibit nucleotide bisyn (1)
|
Ribavirin
|
|
ribonucleoside analog (1)
|
RSV
|
|
inhibit viral DNA polymerase (2)
|
Acyclovir
Ganciclovir |
|
inhibit reverse transcriptase (mxn?) (1)
|
Nevirapine (non-nucleoside HIV RT inhibitor)
|
|
inhibit protein syn
|
interferon alpha
|
|
protease inhibitor (1)
|
Ritonavir
|
|
inhibit Neruaminidase, Hemagglutinin (1) (mxn?)
|
Zanamivir (removes sialic acid on host cell to prevent re-infection after release of new virions)
|